|Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo|
MC Milone, JD Fish, C Carpenito, RG Carroll, GK Binder, D Teachey, ...
Molecular therapy 17 (8), 1453-1464, 2009
|lncRNAdb v2. 0: expanding the reference database for functional long noncoding RNAs|
XC Quek, DW Thomson, JLV Maag, N Bartonicek, B Signal, MB Clark, ...
Nucleic acids research 43 (D1), D168-D173, 2015
|The specificity of long noncoding RNA expression|
BS Gloss, ME Dinger
Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms 1859 (1), 16-22, 2016
|Epigenetic biomarkers in epithelial ovarian cancer|
BS Gloss, G Samimi
Cancer letters 342 (2), 257-263, 2014
|Prognostic and diagnostic significance of DNA methylation patterns in high grade serous ovarian cancer|
C Montavon, BS Gloss, K Warton, CA Barton, AL Statham, JP Scurry, ...
Gynecologic oncology 124 (3), 582-588, 2012
|Unexpected features of the dark proteome|
N Perdig„o, J Heinrich, C Stolte, KS Sabir, MJ Buckley, B Tabor, B Signal, ...
Proceedings of the National Academy of Sciences 112 (52), 15898-15903, 2015
|Computational approaches for functional prediction and characterisation of long noncoding RNAs|
B Signal, BS Gloss, ME Dinger
Trends in Genetics 32 (10), 620-637, 2016
|The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro|
PM O'Brien, MJ Davies, JP Scurry, AN Smith, CA Barton, MJ Henderson, ...
British journal of cancer 98 (6), 1085-1093, 2008
|Integrative genome-wide expression and promoter DNA methylation profiling identifies a potential novel panel of ovarian cancer epigenetic biomarkers|
BS Gloss, KI Patterson, CA Barton, M Gonzalez, JP Scurry, NF Hacker, ...
Cancer letters 318 (1), 76-85, 2012
|Methylation-capture and next-generation sequencing of free circulating DNA from human plasma|
K Warton, V Lin, T Navin, NJ Armstrong, W Kaplan, K Ying, B Gloss, ...
BMC genomics 15 (1), 476, 2014
|MAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma, but differentially associated with histological subtype and patient outcome|
JA Byrne, S Maleki, JR Hardy, BS Gloss, R Murali, JP Scurry, S Fanayan, ...
BMC cancer 10 (1), 497, 2010
|Collagen and calcium-binding EGF domains 1 is frequently inactivated in ovarian cancer by aberrant promoter hypermethylation and modulates cell migration and survival|
CA Barton, BS Gloss, W Qu, AL Statham, NF Hacker, RL Sutherland, ...
British journal of cancer 102 (1), 87-96, 2010
|Long noncoding RNAs CUPID1 and CUPID2 mediate breast cancer risk at 11q13 by modulating the response to DNA damage|
JA Betts, MM Marjaneh, F Al-Ejeh, YC Lim, W Shi, H Sivakumaran, ...
The American Journal of Human Genetics 101 (2), 255-266, 2017
|ZNF300P1 encodes a lincRNA that regulates cell polarity and is epigenetically silenced in type II epithelial ovarian cancer|
B Gloss, K Moran-Jones, V Lin, M Gonzalez, J Scurry, NF Hacker, ...
Molecular cancer 13 (1), 1-10, 2014
|Realizing the significance of noncoding functionality in clinical genomics|
BS Gloss, ME Dinger
Experimental & molecular medicine 50 (8), 1-8, 2018
|Connective tissue growth factor as a novel therapeutic target in high grade serous ovarian cancer|
K Moran-Jones, BS Gloss, R Murali, DK Chang, EK Colvin, MD Jones, ...
Oncotarget 6 (42), 44551, 2015
|IL-21 contributes to fatal inflammatory disease in the absence of Foxp3+ T regulatory cells|
A Vogelzang, HM McGuire, SM Liu, B Gloss, K Mercado, P Earls, ...
The Journal of Immunology 192 (4), 1404-1414, 2014
|Machine learning annotation of human branchpoints|
B Signal, BS Gloss, ME Dinger, TR Mercer
Bioinformatics 34 (6), 920-927, 2018
|Intergenic disease-associated regions are abundant in novel transcripts|
N Bartonicek, MB Clark, XC Quek, JR Torpy, AL Pritchard, JLV Maag, ...
Genome biology 18 (1), 1-16, 2017
|Cyclin E2 is the predominant E-cyclin associated with NPAT in breast cancer cells|
S Rogers, BS Gloss, CS Lee, CM Sergio, ME Dinger, EA Musgrove, ...
Cell division 10 (1), 1-10, 2015